SCHEMBL6986809

SCHEMBL6986809

N#Cc1ccc(CCC(=O)N2CCCc3cc(NC(=O)Cc4ccccc4)ccc32)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.51
NPC1 O15118 1/20 0.51
LMNA P02545 3/20 0.48
TP53 P04637 2/20 0.47
POLB P06746 2/20 0.46
RORC P51449 1/20 0.46
ALDH1A1 P00352 1/20 0.46
FPR1 P21462 2/20 0.45
FPR2 P25090 2/20 0.45
THRB P10828 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6986003 0.94 RAB9A (0.48) RAB9ANPC1TP53ALDH1A1FPR1
SCHEMBL6985377 0.88 RAB9A (0.62) RAB9ANPC1LMNATP53POLB
SCHEMBL6976631 0.87 HSD17B3 (0.46) RAB9ANPC1TP53ALDH1A1FPR1
Hydrochloric Acid SCHEMBL6979970 0.85 TMPRSS2 (0.49) RAB9ANPC1LMNATP53POLB
SCHEMBL6985562 0.85 NR3C1 (0.56) RAB9AALDH1A1FPR1FPR2NR3C1
SCHEMBL6987626 0.84 NR3C1 (0.64) RAB9AALDH1A1FPR1FPR2NR3C1
SCHEMBL6986432 0.84 TP53 (0.48) RAB9ANPC1TP53ALDH1A1FPR1
SCHEMBL6984459 0.83 FPR1 (0.44) RAB9ALMNATP53ALDH1A1FPR1
SCHEMBL7090378 0.83 TP53 (0.47) RAB9ALMNATP53ALDH1A1FPR1
SCHEMBL6983653 0.83 FPR1 (0.44) RAB9ANPC1TP53ALDH1A1FPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed